Literature DB >> 33660077

Understanding interest, barriers, and preferences related to yoga practice among cancer survivors.

Krupali Desai1, Ting Bao2, Qing S Li2, Nirupa J Raghunathan2, Kelly Trevino3, Angela Green4, Han Xiao5, Jun J Mao2.   

Abstract

PURPOSE: Despite growing evidence supporting the benefits of yoga for cancer-related symptom management, yoga usage among cancer survivors is low. To translate the evidence of yoga benefits into community practice, it is critical to understand interest in yoga as well as barriers and preferences that influence yoga usage among cancer survivors.
METHOD: We conducted a cross-sectional survey study among cancer survivors, 18 years or older, with a primary diagnosis of cancer, and receiving treatment or follow-up care at outpatient clinics at five regional academic cancer center sites. We collected data and performed bivariate and multivariable analyses on self-reported yoga usage and interest in and barriers to practicing yoga, as well as preferred location and time for yoga practice.
RESULTS: Of 857 participants, 70.0% had never practiced yoga and 52.3% were interested in practicing yoga. Among those interested, 52.5% had never practiced yoga. Lower interest was independently associated with being male (odds ratio [OR] = 0.30, 95% confidence interval [CI] = 0.20-0.44, p < 0.001), unemployed (OR = 0.60, 95% CI = 0.39-0.91, p = 0.016), and white (OR = 0.42, 95% CI = 0.23-0.78, p = 0.005). Commonly cited barriers among those who were interested but had never practiced were not aware of yoga benefits (36.3%), difficulty motivating (28.7%), experiencing symptoms (22.9%), and not enough time (22.0%). Participants indicated "on-site and at a studio near home" (41.5%) as preferred location and evenings (3-8 pm, 34.0%) as preferred time for yoga practice.
CONCLUSION: Although more than 50% of patients indicated interest in practicing yoga, use of yoga is low among cancer survivors. Barriers and patient preferences for yoga practice need to be addressed to design effective yoga programs for this population.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Barriers; Cancer survivor; Yoga interest

Mesh:

Year:  2021        PMID: 33660077      PMCID: PMC9364436          DOI: 10.1007/s00520-021-06083-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.359


  43 in total

1.  Complementary alternative medicine use among Chinese Americans: findings from a community mental health service population.

Authors:  Lin Fang; Steven P Schinke
Journal:  Psychiatr Serv       Date:  2007-03       Impact factor: 3.084

2.  Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms.

Authors:  Jennifer Huberty; Ryan Eckert; Krisstina Gowin; Jules Mitchell; Amylou C Dueck; Brenda F Ginos; Linda Larkey; Ruben Mesa
Journal:  Haematologica       Date:  2017-06-08       Impact factor: 9.941

3.  Predictors of and barriers to adherence in a 16-week randomised controlled trial of Bikram yoga in stressed and sedentary adults.

Authors:  Zoe L Hewett; Kate L Pumpa; Caroline A Smith; Paul P Fahey; Birinder S Cheema
Journal:  Complement Ther Med       Date:  2018-12-19       Impact factor: 2.446

4.  Enhancing yoga participation: A qualitative investigation of barriers and facilitators to yoga among predominantly racial/ethnic minority, low-income adults.

Authors:  Christine E Spadola; Rebecca Rottapel; Neha Khandpur; Emily Kontos; Suzanne M Bertisch; Dayna A Johnson; Mirja Quante; Sat Bir S Khalsa; Robert B Saper; Susan Redline
Journal:  Complement Ther Clin Pract       Date:  2017-09-04       Impact factor: 2.446

5.  Increasing provider awareness of and recommendations for yoga and meditation classes for cancer patients.

Authors:  Mallory J Koula; Jennifer M Knight
Journal:  Support Care Cancer       Date:  2018-05-04       Impact factor: 3.603

6.  Yoga in adult cancer: an exploratory, qualitative analysis of the patient experience.

Authors:  Marcy McCall; Sally Thorne; Alison Ward; Carl Heneghan
Journal:  BMC Complement Altern Med       Date:  2015-07-22       Impact factor: 3.659

7.  Yoga in the Real World: Perceptions, Motivators, Barriers, and patterns of Use.

Authors:  Mary T Quilty; Robert B Saper; Richard Goldstein; Sat Bir S Khalsa
Journal:  Glob Adv Health Med       Date:  2013-01

8.  Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research.

Authors:  Jennifer Huberty; Ryan Eckert; Amylou Dueck; Heidi Kosiorek; Linda Larkey; Krisstina Gowin; Ruben Mesa
Journal:  BMC Complement Altern Med       Date:  2019-06-07       Impact factor: 3.659

Review 9.  Physical and psychosocial benefits of yoga in cancer patients and survivors, a systematic review and meta-analysis of randomized controlled trials.

Authors:  Laurien M Buffart; Jannique G Z van Uffelen; Ingrid I Riphagen; Johannes Brug; Willem van Mechelen; Wendy J Brown; Mai J M Chinapaw
Journal:  BMC Cancer       Date:  2012-11-27       Impact factor: 4.430

10.  Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005.

Authors:  Heather S Boon; Folashade Olatunde; Suzanna M Zick
Journal:  BMC Womens Health       Date:  2007-03-30       Impact factor: 2.809

View more
  2 in total

1.  Examination of Provider and Patient Knowledge, Beliefs, and Preferences in Integrative Oncology at a National Cancer Institute-Designated Comprehensive Cancer Center.

Authors:  Jennifer S Mascaro; Almira Catic; Meha Srivastava; Maggie Diller; Shaheen Rana; Cam Escoffery; Viraj Master
Journal:  Integr Med Rep       Date:  2022-06-24

2.  Cancer Survivors' Perspectives of Virtual Yoga for Chronic Chemotherapy-Induced Peripheral Neuropathy Pain During the COVID-19 Pandemic.

Authors:  Robert Knoerl; Julianna Bockhoff; Erica Fox; Anita Giobbie-Hurder; Donna L Berry; Juliana Berfield; Jeffrey Meyerhardt; Alexi Wright; Jennifer Ligibel
Journal:  Comput Inform Nurs       Date:  2022-09-01       Impact factor: 2.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.